These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 20960535

  • 21. Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial.
    Kei A, Liberopoulos E, Tellis K, Rizzo M, Elisaf M, Tselepis A.
    Eur J Clin Invest; 2013 Jul; 43(7):698-707. PubMed ID: 23600368
    [Abstract] [Full Text] [Related]

  • 22. A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.
    Filippatos TD.
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):245-55. PubMed ID: 22592524
    [Abstract] [Full Text] [Related]

  • 23. [Rosuvastatin and fenofibrate in patients with diabetes and low high density lipoprotein cholesterol: comparison of changes of lipid levels and some markers of inflammation].
    Polenova NV, Vaulin NA, Masenko VP, Iavelov IS, Gratsianskiĭ NA.
    Kardiologiia; 2009 Jun; 49(2):9-14. PubMed ID: 19254210
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evaluating optimal lipid levels in patients with mixed dyslipidemia following short- and long-term treatment with fenofibric acid and statin combination therapy: a post hoc analysis.
    Mohiuddin SM, Thakker KM, Setze CM, Kelly MT.
    Curr Med Res Opin; 2011 May; 27(5):1067-78. PubMed ID: 21438793
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia.
    Gao F, Ballantyne C, Ma L, Virani SS, Keinan A, Brautbar A.
    Atherosclerosis; 2014 Jun; 234(2):249-53. PubMed ID: 24704626
    [Abstract] [Full Text] [Related]

  • 28. Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemia.
    Capuzzi DM, Morgan JM, Carey CM, Intenzo C, Tulenko T, Kearney D, Walker K, Cressman MD.
    Prev Cardiol; 2004 Jun; 7(4):176-81. PubMed ID: 15539964
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.
    Moutzouri E, Kei A, Elisaf MS, Milionis HJ.
    Vasc Health Risk Manag; 2010 Aug 09; 6():525-39. PubMed ID: 20730069
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
    Brautbar A, Covarrubias D, Belmont J, Lara-Garduno F, Virani SS, Jones PH, Leal SM, Ballantyne CM.
    Atherosclerosis; 2011 Dec 09; 219(2):737-42. PubMed ID: 21889769
    [Abstract] [Full Text] [Related]

  • 38. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN, Tuomilehto J, Hamann A, Kallend D, Smith K.
    Diabetes Res Clin Pract; 2004 May 09; 64(2):137-51. PubMed ID: 15063607
    [Abstract] [Full Text] [Related]

  • 39. Are HIV positive patients resistant to statin therapy?
    Johns KW, Bennett MT, Bondy GP.
    Lipids Health Dis; 2007 Oct 24; 6():27. PubMed ID: 17958912
    [Abstract] [Full Text] [Related]

  • 40. Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
    Davidson MH, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Mazzone T, Carlson DM, Williams LA, Kelly MT, Camp HS, Lele A, Stolzenbach JC.
    Arterioscler Thromb Vasc Biol; 2014 Jun 24; 34(6):1298-306. PubMed ID: 24743431
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.